Approval · Notice of Compliance 14435 · 2013
3TC: Notice of Compliance 14435
Issued June 7, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14435
- Date
- June 7, 2013
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative trasfer of Drug Identification Numbers
- Therapeutic class
- Antiretroviral agent
Products in this notice
Medicinal ingredients
- LAMIVUDINE 10 MG per ML
- LAMIVUDINE 150 MG per TAB
- LAMIVUDINE 300 MG per TAB